Health ❯ Women's Health ❯ Menopause

Hormone Therapy

FDA Regulations Estrogen Therapy Alzheimer's Disease Risk Estrogen Patches Estrogen and Progesterone Contraception Awareness Breast Cancer Risk Sexual Health Treatment Options Testosterone

4 ARTICLES

last mo.

Study Finds Menopausal Hormone Therapy Tied to 69% Lower Odds of Low Bone Density

Real-world DXA data presented at ENDO 2026 indicate estrogen-containing therapy preserves spinal and hip bone mass, but the analysis is observational and not yet peer reviewed.

3 ARTICLES

2mo ago

FDA Says Estrogen Patches Not in Official Shortage as Pharmacies Report Scarcity

4 ARTICLES

7mo ago

Largest Review Finds No Link Between Menopause Hormone Therapy and Dementia Risk

3 ARTICLES

7mo ago

FDA Lifts Broad Black-Box Warnings From Many Menopause Hormone Therapies

7 ARTICLES

7mo ago

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

6 ARTICLES

8mo ago

FDA Removes Broad Boxed Warnings From Many Menopause Hormone Therapies

8 ARTICLES

9mo ago

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

7 ARTICLES

9mo ago

Starting Estrogen in Perimenopause Linked to Lower Cancer and Cardiovascular Risks in Massive EHR Study

6 ARTICLES

9mo ago

AMA Demands National Menopause Framework as Australia Rolls Out Government Initiative

3 ARTICLES

10mo ago

Timing of Menopause Hormone Therapy Linked to Divergent Alzheimer’s Risks

4 ARTICLES

11mo ago

Estradiol Therapy Route Tied to Different Memory Skills After Menopause, Study Finds

4 ARTICLES

last yr.

Fracture Risk Surges After Stopping Menopausal Hormone Therapy, Study Finds

5 ARTICLES

last yr.

FDA Begins Expert Review of Menopause Hormone Therapy Warnings

5 ARTICLES

last yr.

Davina McCall Celebrates All-Clear from Brain Tumour with Women’s Health Feature

3 ARTICLES

last yr.

Menopause Awareness Gains Momentum with Tech and Workplace Support

Hormone Therapy

Study Finds Menopausal Hormone Therapy Tied to 69% Lower Odds of Low Bone Density

FDA Says Estrogen Patches Not in Official Shortage as Pharmacies Report Scarcity

Largest Review Finds No Link Between Menopause Hormone Therapy and Dementia Risk

FDA Lifts Broad Black-Box Warnings From Many Menopause Hormone Therapies

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

FDA Removes Broad Boxed Warnings From Many Menopause Hormone Therapies

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

Starting Estrogen in Perimenopause Linked to Lower Cancer and Cardiovascular Risks in Massive EHR Study

AMA Demands National Menopause Framework as Australia Rolls Out Government Initiative

Timing of Menopause Hormone Therapy Linked to Divergent Alzheimer’s Risks

Estradiol Therapy Route Tied to Different Memory Skills After Menopause, Study Finds

Fracture Risk Surges After Stopping Menopausal Hormone Therapy, Study Finds

FDA Begins Expert Review of Menopause Hormone Therapy Warnings

Davina McCall Celebrates All-Clear from Brain Tumour with Women’s Health Feature

Menopause Awareness Gains Momentum with Tech and Workplace Support

Never miss stories about

Hormone Therapy